Avian Influenza Virus Type A H1N1 subtype HA antibody and antigen (recombinant protein)

Diagnostic anti-Avian Influenza Virus Type A H1N1 subtype HA antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease Avian influenza) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Avian/Bird/Poultry disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P185-Tg002-Ag01 Recombinant Avian Influenza Virus Type A H1N1 subtype HA protein $3090.00
GMP-VT-P185-Tg002-Ab01 Anti-Avian Influenza Virus Type A H1N1 subtype HA mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P185-Tg002-Ab02 Anti-Avian Influenza Virus Type A H1N1 subtype HA mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P185-Tg002-Ab03 Anti-Avian Influenza Virus Type A H1N1 subtype HA human monoclonal antibody (mAb) $3090.00
GMP-VT-P185-Tg002-Ab04 Anti-Avian Influenza Virus Type A H1N1 subtype HA human monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P185-Tg002-Ag01
Product Name Recombinant Avian Influenza Virus Type A H1N1 subtype HA protein
Pathogen Avian Influenza Virus Type A H1N1 subtype
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Avian Influenza Virus Type A H1N1 subtype HA antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Avian Influenza Virus Type A H1N1 subtype level test of animal Avian/Bird/Poultry infectious disease with Avian influenza.
Tag His
Product description Recombinant Avian Influenza Virus Type A H1N1 subtype HA proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P185-Tg002-Ab01,GMP-VT-P185-Tg002-Ab02
Pathogen Avian Influenza Virus Type A H1N1 subtype
Product Name Anti-Avian Influenza Virus Type A H1N1 subtype HA mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Avian Influenza Virus Type A H1N1 subtype HA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Avian Influenza Virus Type A H1N1 subtype antibodies in Avian Influenza Virus Type A H1N1 subtype level test of animal Avian/Bird/Poultry infectious disease with Avian influenza.
Product description Anti-Avian Influenza Virus Type A H1N1 subtype HA mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Avian Influenza Virus Type A H1N1 subtype antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P185-Tg002-Ab03,GMP-VT-P185-Tg002-Ab04
Pathogen Avian Influenza Virus Type A H1N1 subtype
Product Name Anti-Avian Influenza Virus Type A H1N1 subtype HA human monoclonal antibody (mAb)
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Recombinant Avian Influenza Virus Type A H1N1 subtype HA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Avian Influenza Virus Type A H1N1 subtype antibodies in Avian Influenza Virus Type A H1N1 subtype level test of animal Avian/Bird/Poultry infectious disease with Avian influenza.
Product description Anti-Avian Influenza Virus Type A H1N1 subtype HA mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Pathogen Information


    Avian Influenza Virus Type A H1N1 subtype, commonly known as avian flu or bird flu, is a pathogen that causes severe respiratory illness in birds. This virus belongs to the Orthomyxoviridae family, which also includes influenza viruses that infect humans. Avian Influenza Virus Type A H1N1 subtype is a highly contagious virus that can easily spread among birds, and occasionally, it can mutate and infect humans.

    The structure of the Avian Influenza Virus Type A H1N1 subtype is distinctive, consisting of an envelope surrounding segmented RNA that encodes 11 proteins. Two of these proteins are essential for viral entry and exit from host cells: hemagglutinin (HA) and neuraminidase (NA). The HA protein facilitates virus attachment to sialic acid receptors on the surface of host cells, while NA cleaves these receptors to release newly formed virions from infected cells. Other proteins encoded by the virus genome are involved in transcription, replication, and packaging of viral RNA.

    The primary hosts of the Avian Influenza Virus Type A H1N1 subtype are birds, especially domestic poultry such as chickens, turkeys, and ducks. However, this virus can also infect other mammals, including pigs and humans. Wild birds are the natural reservoirs for this virus, and it is thought that migratory birds play a crucial role in the global spread of avian influenza viruses.

    In humans, infection with Avian Influenza Virus Type A H1N1 subtype can cause a range of symptoms, ranging from mild influenza-like illness to severe respiratory distress and even death. Symptoms usually develop within 2-8 days after exposure to the virus and can include fever, cough, sore throat, muscle aches, and fatigue. In severe cases, the infection can progress to pneumonia, acute respiratory distress syndrome (ARDS), or multi-organ failure.

    The diagnosis of Avian Influenza Virus Type A H1N1 subtype infection is crucial for identifying infected individuals and controlling the spread of the virus. Several diagnostic methods are available, including nucleic acid-based tests such as RT-PCR and qPCR that identify specific viral genes such as those encoding HA and NA proteins. Other diagnostic methods include serological tests that detect antibodies to the virus and virus isolation from clinical samples.

    The prevention and control of avian influenza outbreaks require a One Health approach that involves coordination between animal health, public health, and environmental agencies. In birds, vaccination is an essential part of control strategies, along with biosecurity measures to prevent the introduction and spread of the virus within and between farms. In humans, antiviral drugs such as oseltamivir and zanamivir can be effective in treating and preventing the spread of the virus.

    In summary, Avian Influenza Virus Type A H1N1 subtype is a highly contagious virus that primarily infects birds, but can also infect humans and cause serious respiratory illness. Diagnostic methods such as RT-PCR and serological tests are crucial for identifying infected individuals and controlling the spread of the virus. Effective control measures, including vaccination, biosecurity, and antiviral treatment, are essential for preventing and managing avian influenza outbreaks.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.